Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

Abstract Background Trans-arterial radio-embolization (TARE) is an emerging treatment for the management of hepatocellular carcinoma (HCC). TARE may compete with systemic chemotherapy, sorafenib, in intermediate stage patients with prior chemoembolization failure or advanced patients with tumoral ma...

Full description

Bibliographic Details
Main Authors: Carla Rognoni, Oriana Ciani, Silvia Sommariva, Irene Bargellini, Sherrie Bhoori, Roberto Cioni, Antonio Facciorusso, Rita Golfieri, Annagiulia Gramenzi, Vincenzo Mazzaferro, Cristina Mosconi, Francesca Ponziani, Rodolfo Sacco, Franco Trevisani, Rosanna Tarricone
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Trans-arterial radio-embolization
Sorafenib
Budget impact analysis
Costs
Online Access:http://link.springer.com/article/10.1186/s12885-018-4636-7

Similar Items

Similar Items